Guarav Bandi
Papers
1
Total Citations
5
H-Index
1
About
Gaurav Bandi is a leading researcher in radiation oncology, with a focused expertise in stereotactic body radiation therapy (SBRT) for prostate cancer. His work addresses critical gaps in managing treatment failures, particularly through his highly cited 2020 study on isolated local failures following SBRT for low to intermediate risk prostate cancer. This research provides a systematic framework for diagnosing and confirming salvageable local recurrences, offering clinicians evidence-based strategies to optimize patient outcomes after high-dose radiation. Bandi’s contributions are pivotal in refining post-treatment surveillance protocols, leveraging the very low PSA nadirs achieved by SBRT to detect failures early. His work has garnered 5 citations, underscoring its relevance in a niche but clinically vital area. By bridging the gap between advanced radiation delivery and salvage management, Bandi has advanced personalized care for prostate cancer patients, helping to define best practices for managing recurrences while preserving quality of life. His research continues to influence radiation oncology guidelines, making him a key voice in the evolving landscape of prostate cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1